These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 35928449)
1. Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway-Related Prognostic Prediction Model in Gastric Cancer. Jiang F; Chen X; Shen Y; Shen X Front Genet; 2022; 13():891744. PubMed ID: 35928449 [No Abstract] [Full Text] [Related]
2. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer. Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518 [No Abstract] [Full Text] [Related]
3. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer. Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J Front Genet; 2021; 12():661306. PubMed ID: 34249086 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer. Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183 [TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer. Song Y; Qu H BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619 [TBL] [Abstract][Full Text] [Related]
6. Construction and validation of a bladder cancer risk model based on autophagy-related genes. Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018 [TBL] [Abstract][Full Text] [Related]
7. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma. Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203 [TBL] [Abstract][Full Text] [Related]
8. Establishment and Validation of a 5 m6A RNA Methylation Regulatory Gene Prognostic Model in Low-Grade Glioma. Bai Z; Wang X; Zhang Z Front Genet; 2022; 13():655169. PubMed ID: 35281815 [No Abstract] [Full Text] [Related]
9. Identification of a five m6A-relevant mRNAs signature and risk score for the prognostication of gastric cancer. Yin L; Feng S; Sun Y; Jiang Y; Tang C; Sun D J Gastrointest Oncol; 2022 Oct; 13(5):2234-2248. PubMed ID: 36388685 [TBL] [Abstract][Full Text] [Related]
10. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma. Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M Front Oncol; 2021; 11():663263. PubMed ID: 34123820 [TBL] [Abstract][Full Text] [Related]
11. Differential analysis of RNA methylation regulators in gastric cancer based on TCGA data set and construction of a prognostic model. Li J; Zuo Z; Lai S; Zheng Z; Liu B; Wei Y; Han T J Gastrointest Oncol; 2021 Aug; 12(4):1384-1397. PubMed ID: 34532096 [TBL] [Abstract][Full Text] [Related]
12. The development and validation of a m6A-lncRNAs based prognostic model for overall survival in lung squamous cell carcinoma. Huang H; Wu W; Lu Y; Pan X J Thorac Dis; 2022 Oct; 14(10):4055-4072. PubMed ID: 36389308 [TBL] [Abstract][Full Text] [Related]
13. HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer. Jiang R; Wang J; Liang J; Lin D; Mao Q; Cheng S; Huang S; Tong S; Lyu Y; Wei R; Lian Q; Chen H Front Pharmacol; 2022; 13():1096055. PubMed ID: 36712672 [No Abstract] [Full Text] [Related]
14. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma. Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168 [No Abstract] [Full Text] [Related]
15. Identification of an Immune-Related Long Noncoding RNA Pairs Model to Predict Survival and Immune Features in Gastric Cancer. Song S; Liu S; Wei Z; Jin X; Mao D; He Y; Li B; Zhang C Front Cell Dev Biol; 2021; 9():726716. PubMed ID: 34621744 [No Abstract] [Full Text] [Related]
16. Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma. Liao T; Lu Y; Li W; Wang K; Zhang Y; Luo Z; Ju Y; Ouyang M Front Genet; 2022; 13():794621. PubMed ID: 36313430 [No Abstract] [Full Text] [Related]
17. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme. Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H Front Oncol; 2022; 12():938679. PubMed ID: 35982954 [TBL] [Abstract][Full Text] [Related]
18. Screening and validation of platelet activation-related lncRNAs as potential biomarkers for prognosis and immunotherapy in gastric cancer patients. Yuan M; Jia Y; Xing Y; Wang Y; Liu Y; Liu X; Liu D Front Genet; 2022; 13():965033. PubMed ID: 36186426 [No Abstract] [Full Text] [Related]
19. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma. Jin Y; Wang Z; He D; Zhu Y; Hu X; Gong L; Xiao M; Chen X; Cheng Y; Cao K Front Immunol; 2021; 12():637933. PubMed ID: 33746977 [TBL] [Abstract][Full Text] [Related]
20. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients. Wang JM; Li X; Yang P; Geng WB; Wang XY BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]